Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/medecine/assisted-reproductive-technology-surveillance/descriptif_4122434
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=4122434

Assisted Reproductive Technology Surveillance

Langue : Anglais

Coordonnateurs : Kissin Dmitry M., Adamson G. David, Chambers Georgina, De Geyter Christian

Couverture de l’ouvrage Assisted Reproductive Technology Surveillance
Offers a comprehensive guide to assisted reproductive technology surveillance, describing its history, global variations, and best practices.
For over forty years, assisted reproductive technology (ART) has helped millions of patients around the world to overcome infertility. Careful monitoring of ART treatments and their outcomes is vital to maintain the remarkable pace of change in science and technology, whilst minimizing potential risks to infertility patients, and their children. Written by forty-five authors from twenty countries around the world, this book represents a global effort to document the history of assisted reproductive technology surveillance, and its dynamic challenges across the world. Comprehensive in its approach, the text details best practices in collecting and using ART surveillance data to monitor treatment effectiveness and safety, improve quality of care, develop health policy, and provide accurate information to infertility patients, worldwide.
List of contributors; Foreword; Part I. Introduction to Assisted Reproductive Technology Surveillance: 1. Infertility and assisted reproductive technology Sheree L. Boulet, Anjani Chandra, Aaron Rosen and Alan DeCherney; 2. Importance and history of assisted reproductive technology surveillance Jacques de Mouzon, Paul Lancaster and Anders Nyboe Andersen; Part II. General Principles of Assisted Reproductive Technology Surveillance: 3. Assisted reproductive technology surveillance: who, what, when, and how? Sara Crawford, Dmitry M. Kissin and Georgina Chambers; 4. Future directions for assisted reproductive technology surveillance and monitoring novel technology Christian De Geyter and Eli Y. Adashi; Part III. Using Assisted Reproductive Technology Surveillance Data: 5. Reporting assisted reproductive technology success rates Georgina Chambers, Kevin Doody and Sara Crawford; 6. Using assisted reproductive technology surveillance data in clinical research Valerie L. Baker, Sheree L. Boulet and Anja Bisgaard Pinborg; 7. Monitoring assisted reproductive technology safety and biovigilance Luca Gianaroli, Anna Pia Ferraretti and Borut Kovacic; 8. Quality assurance of assisted reproductive technology practice: using data to improve clinical care Kevin Doody, Carlos Calhaz-Jorge and Jesper Smeenk; 9. Monitoring long-term outcomes of assisted reproductive technology: linking surveillance data with other datasets Barbara Luke, Sheree L. Boulet and Anna-Karina Aaris Henningsen; 10. Use of assisted reproductive technology surveillance by infertility patients Sandra K. Dill, Edgar Mocanu and Petra Thorn; Part IV. Global Variations in Assisted Reproductive Technology Surveillance: 11. Global assisted reproductive technology surveillance: data from the international committee monitoring ART (ICMART) G. David Adamson; 12. Global variations in assisted reproductive technology policy: data from the international federation of fertility societies (IFFS) Steven J. Ory and Kathleen Miller; 13. ART surveillance in Africa Silke Dyer, Paversan Archary and G. David Adamson; 14. ART surveillance in Asia Osamu Ishihara, Manish Banker and Bai Fu; 15. ART surveillance in Australia and New Zealand Georgina Chambers, Paul Lancaster and Peter Illingworth; 16. ART surveillance in Europe Christian de Geyter, Markus S. Kupka and Carlos Calhaz-Jorge; 17. ART surveillance in the Middle East Johnny Awwad, Dalia Khalife and Ragaa Mansour; 18. ART surveillance in North America James Patrick Toner, Andrea Lanes and Dmitry M. Kissin; 19. ART surveillance in Latin America Fernando Zegers-Hochschild, Javier A. Crosby and Juan Enrique Schwarze; Part V. Surveillance of Non-ART Fertility Treatments: 20. The role of non-IVF fertility treatments in the management of infertility Christine Wyns, Diane de Neubourg and Eli Y. Adashi; 21. Non-ART surveillance Markus S. Kupka and Anja Bisgaard Pinborg; Appendix A. Assisted reproductive technology surveillance system variables and definitions; Appendix B. International glossary on infertility and fertility care; Appendix C. ICMART data collection form; Index.
Dmitry Kissin is a Epidemiologist and Health Scientist in the area of reproductive health. He received a Doctor of Medicine degree in Obstetrics and Gynecology from St Petersburg State Medical University, Russia and a Master of Public Health degree in Epidemiology from State University of New York. He is leading the ART Surveillance and Research Team in Maternal and Infant Health Branch, Division of Reproductive Health, US Centers for Disease Control and Prevention. His team maintains the National ART Surveillance System and monitors effectiveness and safety of ART in the United States and conducts wide-ranging epidemiological and clinical research on many aspects of infertility and ART. Dr Kissin has published over 100 manuscripts in peer-reviewed journals and several book chapters.
G. David Adamson is a reproductive endocrinologist and surgeon, Clinical Professor ACF at Stanford University, and Associate Clinical Professor at University of California, San Francisco. He is Past President of the American Society for Reproductive Medicine (ASRM), the Society for Assisted Reproductive Technology (SART), AAGL and Fédération Internationale de Gynécologie et d'Obstétrique (FIGO) Reproductive Medicine Committee and several other major gynecological societies. He is Chair of ICMART and President of the World Endometriosis Research Foundation. He has over 300 scientific/medical publications and lectured extensively on ART, endometriosis and infertility. Dr Adamson helped lead development of the FIGO Fertility Toolbox, the Endometriosis Phenome and Biobanking Harmonization Project (EPHect), and he created the Endometriosis Fertility Index. He has also received many awards for contributions to reproductive medicine.
Georgina Chambers is a University of New South Wales (UNSW) Scientia Fellow and Director of National Perinatal Epidemiology and Statistics Unit (NPESU), UNSW. She is the data custodian of the Australian and New Zealand Assisted Reproductive Technology Datab

Date de parution :

Ouvrage de 264 p.

19.2x25.3 cm

Disponible chez l'éditeur (délai d'approvisionnement : 14 jours).

Prix indicatif 127,70 €

Ajouter au panier